CEACAM5 and gastric cancer: Accordingly, Liu et al. identified that the combination of SLC6A3, CEA, and CA19-9 permitted distinguishing GC from healthy volunteers with an AUC of 0.818, higher than that obtained with SLC6A3 alone.